Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Market Dynamics of Track One Patent Strateg...
By
Rene Pretorius
September 26, 2025
In the interconnected landscape of pharmaceutical regulation and innovation, the Track One patent strategy in pharmaceuticals serves as an important component that
Biosimilars Market Trends 2025: Understanding Erosion and Growth
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Su...
Mounjaro Price Increase UK: Impacts on Access and Health Economics
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic ...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Rare Medications Coverage in the Netherlands: Price Reductions Required
« Previous
1
…
3
4
5
6
7
…
45
Next »